| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |